The global market for carotid stents is anticipated to grow at a compound annual growth rate (CAGR) of 6.8%, from USD 605.7 million in 2022 to USD 982.3 million by 2031. North America ought to dominate the market during the forecast period.
The market for carotid stents is experiencing a significant expansion due to the rising incidence of carotid artery diseases and the growing acceptance of less invasive therapies. Improvements in stent design and material technology are improving patient outcomes and driving market expansion. The ageing population and rising incidence of cardiovascular illnesses are further factors propelling market expansion. However, stringent regulatory approval processes and potential issues with carotid stenting procedures could potentially restrict market expansion.
Market Trend: Towards next-generation nitinol-based self-expanding stents for enhanced conformability and flexibility
Next-generation nitinol-based self-expanding stents are clearly taking front stage in the carotid stent industry. Better adaptation to the vascular architecture and lower risk of restenosis are made possible by these advanced stents' improved flexibility and conformability over conventional stainless steel stents. Shape memory and superelasticity are among the special qualities of nitinol that help these stents to keep their form and provide constant radial force across a range of vessel diameters. The rising need for less traumatic and more efficient stenting solutions—especially in difficult anatomies—drives this development.
In order to further increase the design and performance of nitinol-based self-expanding stents, manufacturers are investing in research and development including characteristics like tapered ends and optimal cell shapes to improve deliverability and vessel coverage. These next-generation stents are thus becoming more and more popular among vascular surgeons and interventional cardiologists, hence improving patient outcomes and boosting market expansion.
Market Driver: Increasing carotid artery disease incidence and rising minimally invasive technique acceptance
The carotid stent market is driven in major part by the increasing incidence of carotid artery disorders, especially carotid artery stenosis. Growing numbers of patients needing carotid artery treatments are a result of aging populations, poor lifestyles, and rising prevalence of cardiovascular risk factors like obesity, diabetes, and hypertension. Concurrent with this is an increasing inclination among patients and doctors for least invasive treatments. With possible advantages including shorter hospital stays, fewer recuperation periods, and decreased risk of surgical complications, carotid stenting presents a less invasive substitute for conventional carotid endarterectomy.
Improvements in imaging technology and stent distribution systems, which improve procedure accuracy and safety, help to further justify this change towards minimally invasive techniques. Adoption of carotid stents is predicted to expand as awareness of these advantages rises and more doctors acquire knowledge in carotid stenting procedures, hence boosting market expansion in the next years.
Market Restraint: Strict regulatory approval procedures and possible problems related to carotid stenting treatments
Strict regulatory approval procedures and possible problems connected to carotid stenting operations create difficulties for the market of carotid stent. Before authorizing novel carotid stents, regulatory agencies such the FDA and EMA demand strict standards for safety and effectiveness evidence, which might result in longer development times and higher manufacturing expenses. This regulatory load might stifle new player entrance into the market and hinder creativity. Apart from that, carotid stenting operations expose natural hazards like stent thrombosis, restenosis, and strokes. These possible side effects might affect patient outcomes and cause questions over the long-term safety and effectiveness of carotid stenting among healthcare professionals and patients themselves. For particular patient groups, therefore, some doctors may choose conventional surgical techniques or medical therapy.
Furthermore restricting general acceptance is the need of specific training and knowledge in carotid stenting procedures, especially in areas with restricted access to sophisticated healthcare facilities. These elements together limit the expansion of the industry, hence constant attempts to develop stent technology, modify patient selection criteria, and improve procedural procedures are necessary to reduce hazards and remove regulatory obstacles.
Stent Expansion Dominate the Market
Driven by their great flexibility to artery architecture and lower risk of arterial damage after deployment, self-expanding stents are becoming the main segment in the carotid stent market. Usually composed of nitinol, these stents provide benefits like enhanced long-term patency rates, greater conformability, and constant outward radial force over balloon-expanding stents.
Particularly appropriate for convoluted and calcified carotid arteries, the self-expanding architecture allows for ideal size and lowers the danger of stent migration. Better long-term results also depend on their capacity to change with time regarding vessel remodeling. Their predominance in the carotid stent market is projected to becoming even more stronger as technical developments improve the efficacy of self-expanding stents.
The carotid stent market is led by North America due to its sophisticated healthcare infrastructure and high adoption rates.
Driven by its sophisticated healthcare infrastructure, high acceptance rates of minimally invasive treatments, and great frequency of carotid artery illnesses, North America leads the carotid stent market. The area gains from well-established payment rules, increased awareness of stroke prevention, and an abundance of qualified interventional experts. Particularly the United States dominates the industry with strong clinical research initiatives and early acceptance of creative medical innovations. Major market players and continuous clinical studies help to explain North America's supremacy even further.
Furthermore sustaining the demand for carotid stenting operations is the aging population of the area and great frequency of cardiovascular risk factors. Supported by continuing technology developments and favorable healthcare regulations encouraging minimally invasive procedures, North America is predicted to keep its leading position during the projection period while Europe and Asia-Pacific are expected to see notable increase.
Strong rivalry among important competitors aiming at innovation and market share expansion defines the carotid stent industry. Prominent firms are concentrating on creating next-generation stents with better deliverability, flexibility, and long-term results. Common as companies try to improve their product lines and worldwide presence are strategic alliances, mergers, and acquisitions. With an eye toward improving stent designs, materials, and delivery methods, research and development expenditures are somewhat large. Key approaches to enter developing markets include regional expansions and alliances with healthcare providers. Maintaining competitive advantage depends still mostly on clinical evidence creation and regulatory compliance.
Companies are also investigating complementary technologies including embolic protection devices to provide complete carotid artery disease management options as the industry develops. The entrance of new players and continuous technical developments in the sector should cause the competitive scene to become more intense.
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Cardinal Health, Inc.
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- Biotronik SE & Co. KG
- Balton Sp. z o.o.
- InspireMD, Inc.
- Contego Medical, LLC
1. INTRODUCTION
1.1. Market Definition
1.2. Study Scope
1.3. Currency Conversion
1.4. Study Period (2022- 2031)
1.5. Regional Coverage
2. RESEARCH METHODOLOGY
2.1. Primary Research
2.2. Secondary Research
2.3. Company Share Analysis
2.4. Data Triangulation
3. EXECUTIVE SUMMARY
3.1. Global Carotid Stent Market (2018 – 2022)
3.2. Global Carotid Stent Market (2023 – 2031)
3.2.1. Market Segment By Type (2023 – 2031)
3.2.2. Market Segment By Material (2023 – 2031)
3.2.3. Market Segment By End-User (2023 – 2031)
4. MARKET DYNAMICS
4.1. Market Trends
4.1.1. Shift towards next-generation nitinol-based self-expanding stents for improved flexibility and conformability
4.1.2. Increasing focus on dual-layer stent designs for enhanced plaque coverage
4.1.3. Growing adoption of robotic-assisted carotid stenting procedures
4.2. Market Drivers
4.2.1. Increasing prevalence of carotid artery diseases and growing adoption of minimally invasive procedures
4.2.2. Technological advancements in stent materials and designs
4.2.3. Rising geriatric population and associated cardiovascular risks
4.3. Market Restraints
4.3.1. Stringent regulatory approval processes and potential complications associated with carotid stenting procedures
4.3.2. Limited reimbursement policies in developing regions
4.4. Porter's Five Forces Analysis
4.4.1. Threat of New Entrants
4.4.2. Bargaining Power of Buyers/Consumers
4.4.3. Bargaining Power of Suppliers
4.4.4. Threat of Substitute Products
4.4.5. Intensity of Competitive Rivalry
4.5. Supply Chain Analysis
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Pipeline Analysis
5. BY TYPE (MARKET VALUE (US$ MILLION) – 2022-2031*)
5.1. Balloon-Expandable Stents
5.2. Self-Expanding Stents
6. BY MATERIAL
6.1. Nitinol
6.2. Cobalt-Chromium
6.3. Others
7. BY END-USER
7.1. Hospitals
7.2. Ambulatory Surgical Centers
7.3. Specialty Clinics
8. GEOGRAPHY
8.1. North America
8.1.1. United States
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Rest of South America
8.3. Europe
8.3.1. Germany
8.3.2. United Kingdom
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle-East
8.5.1. UAE
8.5.2. Saudi Arabia
8.5.3. Turkey
8.5.4. Rest of Middle East
8.6. Africa
8.6.1. South Africa
8.6.2. Egypt
8.6.3. Rest of Africa
9. COMPETITIVE LANDSCAPE
9.1. Key Developments
9.2. Company Market Share Analysis
9.3. Product Benchmarking
10. SWOT ANALYSIS
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.2. Boston Scientific Corporation
11.3. Medtronic plc
11.4. Cardinal Health, Inc.
11.5. Terumo Corporation
11.6. W. L. Gore & Associates, Inc.
11.7. Biotronik SE & Co. KG
11.8. Balton Sp. z o.o.
11.9. InspireMD, Inc.
11.10. Contego Medical, LLC
11.11. Silk Road Medical, Inc.
11.12. MicroPort Scientific Corporation (*LIST NOT EXHAUSTIVE)
12. MARKET OPPORTUNITIES
By Type:
- Balloon-Expandable Stents
- Self-Expanding Stents
By Material:
- Nitinol
- Cobalt-Chromium
- Others
By End-User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511
